Literature DB >> 21128770

Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.

Yunyi Kong1, Suresh M Kumar, Xiaowei Xu.   

Abstract

Recent advances in molecular genetics and cancer stem cell biology have shed some light on the molecular basis of melanomagenesis. In this review, we will focus on major genetic alterations in the melanoma, particularly pathways involved in cell proliferation, apoptosis, and tumor suppression. The potential role of melanoma-initiating cells during melanomagenesis and progression will also be discussed. Understanding pathogenesis of melanoma may uncover new diagnostic clues and therapeutic targets for this increasingly prevalent disease.

Entities:  

Mesh:

Year:  2010        PMID: 21128770      PMCID: PMC4049155          DOI: 10.5858/2009-0418-RAR.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  129 in total

1.  Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.

Authors:  A Birck; V Ahrenkiel; J Zeuthen; K Hou-Jensen; P Guldberg
Journal:  J Invest Dermatol       Date:  2000-02       Impact factor: 8.551

2.  PI3-kinase subunits are infrequent somatic targets in melanoma.

Authors:  John A Curtin; Mitchell S Stark; Daniel Pinkel; Nicholas K Hayward; Boris C Bastian
Journal:  J Invest Dermatol       Date:  2006-04-13       Impact factor: 8.551

3.  An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.

Authors:  Keiran S M Smalley; Rooha Contractor; Nikolas K Haass; Angela N Kulp; G Ekin Atilla-Gokcumen; Douglas S Williams; Howard Bregman; Keith T Flaherty; Maria S Soengas; Eric Meggers; Meenhard Herlyn
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

4.  Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

Authors:  A van Elsas; S F Zerp; S van der Flier; K M Krüse; C Aarnoudse; N K Hayward; D J Ruiter; P I Schrier
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

5.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

Review 6.  The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-28       Impact factor: 4.693

7.  The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.

Authors:  Hong Yu; Ronan McDaid; John Lee; Patricia Possik; Ling Li; Suresh M Kumar; David E Elder; Patricia Van Belle; Phyllis Gimotty; Matt Guerra; Rachel Hammond; Katharine L Nathanson; Maria Dalla Palma; Meenhard Herlyn; Xiaowei Xu
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

8.  Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions.

Authors:  T Papp; M Jafari; D Schiffmann
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 9.  Melanoma: molecular pathogenesis and emerging target therapies (Review).

Authors:  Alessia E Russo; Elena Torrisi; Ylenia Bevelacqua; Rosario Perrotta; Massimo Libra; James A McCubrey; Demetrios A Spandidos; Franca Stivala; Grazia Malaponte
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

10.  Mutations of the BRAF gene in benign and malignant melanocytic lesions.

Authors:  Amir S Yazdi; Gabriele Palmedo; Michael J Flaig; Ursula Puchta; Andrea Reckwerth; Arno Rütten; Thomas Mentzel; Heino Hügel; Markus Hantschke; Monika-Hildegard Schmid-Wendtner; Heinz Kutzner; Christian A Sander
Journal:  J Invest Dermatol       Date:  2003-11       Impact factor: 8.551

View more
  11 in total

Review 1.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

2.  Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.

Authors:  Anna V Kudryavtseva; Maria S Fedorova; Alex Zhavoronkov; Alexey A Moskalev; Alexander S Zasedatelev; Alexey A Dmitriev; Asiya F Sadritdinova; Irina Y Karpova; Kirill M Nyushko; Dmitry V Kalinin; Nadezhda N Volchenko; Nataliya V Melnikova; Kseniya M Klimina; Dmitry V Sidorov; Anatoly Y Popov; Tatiana V Nasedkina; Andrey D Kaprin; Boris Y Alekseev; George S Krasnov; Anastasiya V Snezhkina
Journal:  BMC Genet       Date:  2016-12-22       Impact factor: 2.797

3.  Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma.

Authors:  Jonathan C Dudley; Grzegorz T Gurda; Li-Hui Tseng; Derek A Anderson; Guoli Chen; Janis M Taube; Christopher D Gocke; James R Eshleman; Ming-Tseh Lin
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

Review 4.  Molecular genetic and immunotherapeutic targets in metastatic melanoma.

Authors:  C Melis; A Rogiers; O Bechter; Joost J van den Oord
Journal:  Virchows Arch       Date:  2017-03-29       Impact factor: 4.064

5.  Molecular bases of cutaneous and uveal melanomas.

Authors:  Sudeep Gaudi; Jane L Messina
Journal:  Patholog Res Int       Date:  2011-08-18

6.  c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.

Authors:  S S Ganguly; L S Fiore; J T Sims; J W Friend; D Srinivasan; M A Thacker; M L Cibull; C Wang; M Novak; D M Kaetzel; R Plattner
Journal:  Oncogene       Date:  2011-09-05       Impact factor: 9.867

7.  A case-control study of the risk of cutaneous melanoma associated with three selenium exposure indicators.

Authors:  Marco Vinceti; Catherine M Crespi; Carlotta Malagoli; Ilaria Bottecchi; Angela Ferrari; Sabina Sieri; Vittorio Krogh; Dorothea Alber; Margherita Bergomi; Stefania Seidenari; Giovanni Pellacani
Journal:  Tumori       Date:  2012 May-Jun

8.  Nucleotide excision repair deficiency in melanoma in response to UVA.

Authors:  Heather C Murray; Vicki E Maltby; Doug W Smith; Nikola A Bowden
Journal:  Exp Hematol Oncol       Date:  2016-02-24

9.  Mutations in Coagulation Factor VIII Are Associated with More Favorable Outcome in Patients with Cutaneous Melanoma.

Authors:  Zheng Ping; Abha Soni; Lance A Williams; Huy P Pham; Malay K Basu; X Long Zheng
Journal:  TH Open       Date:  2017-07

10.  MAP Kinase Pathways: Molecular Roads to Primary Acral Lentiginous Melanoma.

Authors:  Juliana D Fernandes; Ricardo Hsieh; Luiz A R de Freitas; Miguel A R Brandao; Silvia V Lourenço; Martin Sangueza; Marcello M S Nico
Journal:  Am J Dermatopathol       Date:  2015-12       Impact factor: 1.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.